Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Morgan

Showing results (171-180 of 297) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|June 1, 1991
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samplesS R Hammans, M G Sweeney, M Brockington, et al.
Drug and Alcohol Dependence|February 23, 2010
Attentional bias, inhibitory control and acute stress in current and former opiate addictsNatasha Constantinou, Celia J A Morgan, Stefania Battistella, et al.
Pharmacopsychiatry|April 19, 2012
Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaineC J A Morgan, S Duffin, S Hunt, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1994
Elimination of glutathione-induced protection from hyperbaric hyperoxia by acivicinM D Peacock, D A Schenk, R A Lawrence, et al.
Translational Psychiatry|September 7, 2018
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory functionCelia J A Morgan, Tom P Freeman, Chandni Hindocha, et al.
Psychopharmacology|May 15, 2009
Global impairment of prospective memory following acute alcoholJulie R Leitz, Celia J A Morgan, James A Bisby, et al.
Journal of Medical Genetics|June 1, 1982
Isozyme patterns and protein profiles in neuromuscular disordersY H Edwards, T D Tipler, J A Morgan-Hughes, et al.
Biochemical Pharmacology|February 15, 1988
Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. An animal model of impaired oxidative phosphorylation (mitochondrial myopathy)J M Cooper, R K Petty, D J Hayes, et al.
Psychopharmacology|August 10, 2006
Greater vulnerability to the amnestic effects of ketamine in malesCelia J A Morgan, Edward B Perry, Hyung-Sang Cho, et al.
Brain : a Journal of Neurology|April 1, 1992
A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathiesS R Hammans, M G Sweeney, D A Wicks, et al.
Pageof 30

Showing results (171-180 of 297) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|June 1, 1991
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samplesS R Hammans, M G Sweeney, M Brockington, et al.
Drug and Alcohol Dependence|February 23, 2010
Attentional bias, inhibitory control and acute stress in current and former opiate addictsNatasha Constantinou, Celia J A Morgan, Stefania Battistella, et al.
Pharmacopsychiatry|April 19, 2012
Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaineC J A Morgan, S Duffin, S Hunt, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1994
Elimination of glutathione-induced protection from hyperbaric hyperoxia by acivicinM D Peacock, D A Schenk, R A Lawrence, et al.
Translational Psychiatry|September 7, 2018
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory functionCelia J A Morgan, Tom P Freeman, Chandni Hindocha, et al.
Psychopharmacology|May 15, 2009
Global impairment of prospective memory following acute alcoholJulie R Leitz, Celia J A Morgan, James A Bisby, et al.
Journal of Medical Genetics|June 1, 1982
Isozyme patterns and protein profiles in neuromuscular disordersY H Edwards, T D Tipler, J A Morgan-Hughes, et al.
Biochemical Pharmacology|February 15, 1988
Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. An animal model of impaired oxidative phosphorylation (mitochondrial myopathy)J M Cooper, R K Petty, D J Hayes, et al.
Psychopharmacology|August 10, 2006
Greater vulnerability to the amnestic effects of ketamine in malesCelia J A Morgan, Edward B Perry, Hyung-Sang Cho, et al.
Brain : a Journal of Neurology|April 1, 1992
A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathiesS R Hammans, M G Sweeney, D A Wicks, et al.
Pageof 30